Chapter 16 Case studies of ibogaine treatment: Implications for patient management strategies

Howard S. Lotsof, Norma E Alexander

The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology January 1, 2001 Peer reviewed DOI: 10.1016/s0099-9598(01)56020-4 via OpenAlex

Relevant Not relevant

Abstract

No abstract available from the source.

Tags

Modalities Psychology Psychotherapist Psychiatry Intensive care medicine

Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Psychedelics. • October 28, 2025 • via OpenAlex
Therapeutic use of psilocybin: Practical considerations for dosing and administration Frontiers in Psychiatry • December 1, 2022 • via OpenAlex
Ibogaine therapy in the treatment of opiate dependency Drugs and Alcohol Today • December 2, 2010 • via OpenAlex
Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome ACS Medicinal Chemistry Letters • August 15, 2025 • via OpenAlex
From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence‐Based Policy and Practice Pharmacology Research & Perspectives • April 1, 2025 • via OpenAlex

Comments

No comments yet.

Log in to comment

Abstract

Tags

Related reading

Comments